| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. | Chief Scientific Officer | Stock Option | 171K | 16 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INKT | MiNK Therapeutics, Inc. | 16 Jan 2024 | 2 | $0 | 4 | Chief Scientific Officer | 18 Jan 2024, 20:00 |
| INKT | MiNK Therapeutics, Inc. | 09 Jan 2023 | 2 | $63.5K | 4 | Chief Scientific Officer | 12 Jan 2023, 09:48 |
| INKT | MiNK Therapeutics, Inc. | 09 Jan 2023 | 1 | $0 | 4 | Chief Scientific Officer | 11 Jan 2023, 16:26 |
| INKT | MiNK Therapeutics, Inc. | 21 Jan 2022 | 1 | $0 | 4 | Chief Technology Officer | 25 Jan 2022, 16:19 |
| INKT | MiNK Therapeutics, Inc. | 13 Oct 2021 | 0 | $0 | 3 | Chief Technology Officer | 20 Oct 2021, 18:52 |